Akero - AKRO Quarterly Revenue Growth

Akero Therapeutics (AKRO) - corporate logo

Akero Therapeutics (AKRO) lacks stable cash flows, as it relies exclusively on external capital until its products reach the market. The company's quarterly revenue growth, as seen on the GURU.Markets chart, shows that 0.00 is hitting a new level, while the business risks a collapse in capitalization due to potential failures in liver drug trials. However, the diversification of several metabolic pathology research programs mitigates the overall risks.

AKRO Akero Therapeutics Inc Quarterly Sales Growth Rate (07/04/2022 - 12/20/2025)

Summary analytical data breakdowns for Akero Therapeutics, Inc. (AKRO)

- current quotes and average value forecast:
Analysis of all company metrics:Akero Therapeutics, Inc. (AKRO)
Manufactured products of Akero

A fundamental risk assessment requires an analysis of actual sales dynamics, where quarter-over-quarter revenue growth rates allow for the filtering of inflationary noise and the identification of fading commercial momentum. For Akero Therapeutics (AKRO), this metric reflects market demand for its AI solutions and robotic bioanalysis systems, demonstrating the efficiency of clinical test automation through the percentage change in revenue between consecutive periods.

Main competitors

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Metsera Therapeutics|MoonLake Corp (MLTX) - Quarterly Sales Growth Rate|Revenue Growth QoQ crinetics.com (CRNX)|Quarterly Sales Growth newamsterdampharma.com NAMS|Revenue Growth QoQ Soleno Therapeutics Inc SLNO|Quarterly Revenue Growth Amicus Therapeutics Inc FOLD|89bio Corp - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Revenue Growth QoQ|Quarterly Sales Growth MiMedx Group, Inc.|Revenue Growth QoQ Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate